These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 17668366)

  • 1. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteases of malaria parasites: new targets for chemotherapy.
    Rosenthal PJ
    Emerg Infect Dis; 1998; 4(1):49-57. PubMed ID: 9452398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malaria prophylaxis and treatment: problems, recent developments and perspectives].
    Pradines B; Vial H; Olliaro P
    Med Trop (Mars); 2003; 63(1):79-98. PubMed ID: 12891756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmepsins as potential targets for new antimalarial therapy.
    Ersmark K; Samuelsson B; Hallberg A
    Med Res Rev; 2006 Sep; 26(5):626-66. PubMed ID: 16838300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting parasite-mediated host hemoglobin degradation in malaria.
    Rathore D
    IDrugs; 2007 Dec; 10(12):877-80. PubMed ID: 18041685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
    He Z; Chen L; You J; Qin L; Chen X
    Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance in malaria.
    Parija SC; Praharaj I
    Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant malaria: molecular mechanisms and implications for public health.
    Petersen I; Eastman R; Lanzer M
    FEBS Lett; 2011 Jun; 585(11):1551-62. PubMed ID: 21530510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
    Muthas D; Nöteberg D; Sabnis YA; Hamelink E; Vrang L; Samuelsson B; Karlén A; Hallberg A
    Bioorg Med Chem; 2005 Sep; 13(18):5371-90. PubMed ID: 16054370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
    Babiker HA; Hastings IM; Swedberg G
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to reverse drug resistance in malaria.
    Egan TJ; Kaschula CH
    Curr Opin Infect Dis; 2007 Dec; 20(6):598-604. PubMed ID: 17975410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.